Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit
Author(s) -
Tan Doan,
Carl M. J. Kirkpatrick,
Patricia Walker,
Monica A. Slavin,
Michelle AnandaRajah,
C. Orla Morrissey,
Karen Urbancic,
Andrew Grigg,
Andrew Spencer,
Jeff Szer,
John F. Seymour,
David C. M. Kong
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv343
Subject(s) - medicine , antifungal , audit , lymphoblastic leukemia , pediatrics , intensive care medicine , leukemia , dermatology , management , economics
The primary objectives were to investigate the prescribing practices of primary antifungal prophylaxis (PAP) and incidence of invasive fungal disease (IFD) in adult patients with ALL receiving induction-consolidation chemotherapy. Secondary objectives were to determine risk factors for IFD and resource utilization associated with IFD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom